Learn more about the use of mHealth technology
in the mental health care
This is the reposting of an original article written by Centra Group. You can read the original article here. Monsenso is proud to announce a new working partnership with UK's telecare provider, Centra. The joint work will explore new, digital approaches to mental...
Monsenso updates quality management system with new 2016 revision of ISO 13485 & annual audit of ISO 27001
Monsenso mHealth solution was audited to a new 2016 revision of ISO 13485. With the new revision Monsenso clinic has implemented in its quality management system expanded risk management approach. Moreover, Monsenso is now more compliant with requirements on the US market.
Peter Hagelund beskriver, hvordan brugen af Monsenso mHealth løsning kunne have hjulpet ham og hans psykiater med at diagnosticere hans bipolare lidelse type 2 tidligere, og derved reddet ham fra måneder med angst og forvirring.
Peter Hagelund discusses how Monsenso’s mHealth solution has helped his psychiatrist diagnose his Bipolar Disorder Type 2 more quickly and accurately, helping him avoid further months of anxiety and confusion.
“Monsenso helps me to maintain balance between manic and depressive episodes.” Mads Trier-Blom’s Customer Story
In this video, Monsenso user Mads Trier-Blom speaks of his experience using the Monsenso app as a part of a clinical trial. The Monsenso app helped him to become more aware of his mood, and other factors, such as sleep, and their influence on his bipolar affective disorder.
Swedish Psychiatrist Kristoffer Södersten shares his experience using the Monsenso clinic to help treat his clients, and talks about how mobile health has helped him improve delivering psychiatric treatment.
In this video, Monsenso User Peter Hagelund speaks about his experience using our mobile health solution to support his bipolar disorder treatment, and how the solution has helped improve and inform his communication with his psychiatrist.
Our mHealth solution helps build well-being through innovation by collecting data for a wide variety of research projects studying affective disorders. Learn more about our past, and ongoing projects, here.
Monsenso provides medication adherence and behavioural monitoring components in H2020 Funded R-LiNK Study
Monsenso is participating in R-LiNK, the major new study for developing a more complete understanding of the reactions and effects of taking lithium. Monsenso is now involved in more than ten pan European and domestic research projects in the mental health & affective disorders field.
Big data can transform the mental health and life science industry. CPO Mads Frost writes a guest blog about how Monsenso’s mHealth solution offers new ways to inform treatment.